Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-EN Version v3-EN
Language English English
Date Updated 2021-03-18 2020-08-21
Drug Identification Number 02441632 02441632
Brand name TEVA-CINACALCET TEVA-CINACALCET
Common or Proper name TEVA-CINACALCET 60MG TABS TEVA-CINACALCET 60MG TABS
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients CINACALCET CINACALCET
Strength(s) 60MG 60MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30 30
ATC code H05BX H05BX
ATC description ANTI-PARATHYROID HORMONES ANTI-PARATHYROID HORMONES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-08-20 2020-08-20
Estimated end date Unknown
Actual end date 2021-03-17
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments